Mwanzo002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Bei iliyotangulia
¥ 29.86
Bei za siku
¥ 29.56 - ¥ 30.08
Bei za mwaka
¥ 23.50 - ¥ 38.10
Thamani ya kampuni katika soko
33.27B CNY
Wastani wa hisa zilizouzwa
4.60M
Uwiano wa bei na mapato
54.22
Mgao wa faida
1.68%
Ubadilishanaji wa msingi
SHE
Habari za soko
The Straits Times
siku 2 zilizopita
Nasdaq, S&P 500 fall as China's DeepSeek AI model hits tech shares
0.47%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 958.43M | 24.15% |
Matumizi ya uendeshaji wa biashara | 512.65M | 45.09% |
Mapato halisi | 165.62M | 17.01% |
Kiwango cha faida halisi | 17.28 | -5.78% |
Mapato kwa kila hisa | — | — |
EBITDA | 279.38M | 19.13% |
Asilimia ya kodi ya mapato | 5.44% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.91B | -4.84% |
Jumla ya mali | 10.23B | 8.51% |
Jumla ya dhima | 1.59B | 6.97% |
Jumla ya hisa | 8.64B | — |
hisa zilizosalia | 1.11B | — |
Uwiano wa bei na thamani | 3.87 | — |
Faida inayotokana na mali | 4.96% | — |
Faida inayotokana mtaji | 5.93% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 165.62M | 17.01% |
Pesa kutokana na shughuli | 320.85M | 76.79% |
Pesa kutokana na uwekezaji | -533.90M | -36.02% |
Pesa kutokana na ufadhili | 308.40M | 245.90% |
Mabadiliko halisi ya pesa taslimu | 88.19M | 170.79% |
Mtiririko huru wa pesa | -1.21B | -19.69% |
Kuhusu
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Ilianzishwa
3 Nov 1998
Tovuti
Wafanyakazi
3,517
